GlassScriptPhysician profile
Gregory N Sacher
NPI 1972682011
$3,143.16
in general payments reported to CMS, 2019-2025
30 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $553 · 2021: $439 · 2022: $854 · 2023: $588 · 2024: $19.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $588.07 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $469.97 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Therapeuticsmd, INC. | $395.95 | 2019-2022 | |
| Hologic Sales and Service, LLC | $348.66 | 2019-2023 | Aptima |
| Mayne Pharma Commercial LLC | $243.95 | 2021-2023 | |
| Amag Pharmaceuticals, INC. | $176.79 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $155.17 | 2019-2023 | |
| Myovant Sciences INC. | $129.56 | 2021-2022 | |
| Organon LLC | $118.78 | 2022-2024 | Nexplanon |
| Avanos Medical | $112.87 | 2022-2023 | On-Q* Pump and Accessories |
| Astellas Pharma US INC | $112.53 | 2019-2023 | Veozah |
| Acessa Health INC. | $107.37 | 2021 | |
| Pfizer INC. | $89.04 | 2022-2023 | |
| Evofem Biosciences, INC. | $87.64 | 2021-2023 | Phexxi |
| Merck Sharp & Dohme LLC | $72.85 | 2019-2020 | |
| Shield Therapeutics INC | $49.86 | 2023 | Accrufer |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $48.67 | 2020 | |
| Daiichi Sankyo INC. | $43.93 | 2019 | |
| Coopersurgical, INC. | $42.96 | 2019-2020 | |
| Stryker Corporation | $42.13 | 2021 | |
| Sumitomo Pharma America, INC. | $39.88 | 2023 | Myfembree |
| Sage Therapeutics, LLC | $38.60 | 2019-2022 | |
| Boston Scientific Corporation | $36.30 | 2021 | |
| Ethicon US, LLC | $35.79 | 2020-2022 | |
| Convatec INC. | $24.47 | 2022 | |
| Sagent Pharmaceuticals | $24.02 | 2022 | |
| Laborie Medical Technologies Corp. | $20.90 | 2020 | |
| Aspira Women'S Health INC | $20.30 | 2022 | |
| Becton, Dickinson and Company | $18.53 | 2019 | |
| Agile Therapeutics, INC. | $18.46 | 2021 | |
| Allergan, INC. | $17.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Sacher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.